Allarity Therapeutics Inc (ALLR)

$0.2

Market is closed - opens 7 PM, 17 Jul 2024

Performance

  • $0.19
    $0.21
    $0.20
    downward going graph

    6.45%

    Downside

    Day's Volatility :8.78%

    Upside

    2.49%

    downward going graph
  • $0.18
    $69.00
    $0.20
    downward going graph

    9.7%

    Downside

    52 Weeks Volatility :99.74%

    Upside

    99.71%

    downward going graph

Returns

PeriodAllarity Therapeutics IncIndex (Russel 2000)
3 Months
-86.44%
0.0%
6 Months
-97.9%
0.0%
1 Year
-93.46%
0.0%
3 Years
-100.0%
-18.2%

Highlights

Market Capitalization
5.1M
Book Value
- $23.28
Earnings Per Share (EPS)
2032.59
PE Ratio
0.0
Wall Street Target Price
5.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-89.69%
Return On Equity TTM
-20995.16%
Revenue TTM
-7.1M
Revenue Per Share TTM
-0.02
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
-36.3M
EBITDA
-17.7M
Diluted Eps TTM
2032.59
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-2.6
EPS Estimate Next Year
-1.56
EPS Estimate Current Quarter
-1.76
EPS Estimate Next Quarter
-0.29

Analyst Recommendation

Sell
    0
    0%Buy
    50%Hold
    50%Sell
Based on 6 Wall street analysts offering stock ratings for Allarity Therapeutics Inc(by analysts ranked 0 to 5 stars)
Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
00
Hold
3
3
3
Sell
3
3
3

Analyst Forecast

What analysts predicted

Upside of 2400.0%

Current $0.20
Target $5.00

Technicals Summary

Sell

Neutral

Buy

Allarity Therapeutics Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Allarity Therapeutics Inc
Allarity Therapeutics Inc
-53.9%
-97.9%
-93.46%
-100.0%
-100.0%
Moderna, Inc.
Moderna, Inc.
-9.25%
24.7%
2.07%
-60.09%
791.95%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
4.75%
17.85%
51.74%
87.1%
265.7%
Novo Nordisk A/s
Novo Nordisk A/s
0.36%
32.05%
75.05%
218.96%
483.19%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.23%
12.73%
36.59%
145.42%
176.04%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Allarity Therapeutics Inc
Allarity Therapeutics Inc
0.0
0.0
NA
-2.6
-209.95
-0.9
NA
-23.28
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.94
31.94
1.46
44.22
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
48.76
48.76
2.36
3.45
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
17.07
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Allarity Therapeutics Inc
Allarity Therapeutics Inc
Sell
$5.1M
-100.0%
0.0
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$48.0B
791.95%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$119.2B
265.7%
31.94
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$633.1B
483.19%
48.76
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
176.04%
31.85
39.46%

Insights on Allarity Therapeutics Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 75.0% return, outperforming this stock by 168.5%

Institutional Holdings

    Company Information

    oncology venture is a drug development company formed in 2012 dedicated to unlock the potential of new oncology products, and rescue failed drugs. our method improves the efficacy of the drugs, increase the response rate in cancer patients, reduce timelines and improve success rates in oncology drug development.

    Organization
    Allarity Therapeutics Inc
    Employees
    5
    CEO
    Mr. Thomas H. Jensen
    Industry
    Miscellaneous

    FAQs